The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
How and when are Japanese patients with unresectable/metastatic cancer seeking a second opinion of treatment options? Analysis of patients? backgrounds.
 
Yasutsuna Sasaki
Speakers' Bureau - Chugai Pharma; Eisai; Kyowa Hakko Kirin; Merck Serono; Taiho Pharmaceutical; Takeda
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb Japan (Inst); Daiichi Sankyo (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst); Yakult Honsha (Inst)
 
Shigehira Saji
Honoraria - AstraZeneca; Chugai Pharma; Eisai; Novartis; Pfizer
Consulting or Advisory Role - Eisai; Novartis
Research Funding - Chugai Pharma
 
Fumio Nagashima
Consulting or Advisory Role - Janssen
Research Funding - Daiichi Sankyo; Lilly; Sanofi; Sumitomo Dainippon; Taiho Pharmaceutical
 
Yuichi Ando
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Eisai; Janssen; Kyowa Hakko Kirin; Lilly; Merck Serono; Novartis; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical; Takeda; Yakult Honsha
Consulting or Advisory Role - Boehringer Ingelheim; Daiichi Sankyo; GlaxoSmithKline; Novartis; Ono Pharmaceutical; Parexel
Research Funding - Chugai Pharma (Inst); Hisamitsu Pharmaceutical (Inst); Kyowa Hakko Kirin (Inst); Merck Serono (Inst); Mitsubishi Tanabe Pharma (Inst); Mochida Pharmaceutical Co. Ltd. (Inst); Nippon Kayaku (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Torii Pharmaceutical (Inst); Yakult Honsha (Inst)
 
Toshimichi Miya
Consulting or Advisory Role - Merck Serono
 
Wataru Ichikawa
Honoraria - Bayer; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Merck Serono; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Daiichi Sankyo; Merck Serono; Zeria Pharmaceutical
Research Funding - Taiho Pharmaceutical; Takeda
Travel, Accommodations, Expenses - Daiichi Sankyo
 
Ken Shimada
No Relationships to Disclose